Multi-center randomized controlled trial of CT-guided radiofrequency ablation versus SBRT in the treatment of multiple primary early-stage diabetes mellitus after single surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027031

Enrollment

Unknown

Registered

2019-10-29

Start date

2020-06-29

Completion date

Unknown

Last updated

2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Experimental group:CT guided radiofrequency ablation

Control group:stereotactic body radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Postoperative diagnosis of early-stage lung cancer; 2. Postoperatively, multiple primary or peripheral lung nodules confirmed by multidisciplinary consultation and histopathology in the lung; 3. Reconstructive surgery can not be tolerated due to poor cardiopulmonary function, advanced age, and other reasons; 4. The maximum diameter of a single lesion is no more than 5cm.

Exclusion criteria

Exclusion criteria: 1. Major organ failure (heart, liver, lung, and kidney); 2. Uncorrectable coagulopathy; 3. Multiple metastases in the lung; 4. Active infection; 5. lymph node metastasis and distant metastasis (N0M0).

Design outcomes

Primary

Measure	Time frame
Disease-free survival;	—

Countries

China

Contacts

Public ContactHua Zhong

Shanghai Chest Hospital, Shanghai Jiaotong University

eddiedong8@hotmail.com+86 13818200560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026